<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02822885</url>
  </required_header>
  <id_info>
    <org_study_id>sleem</org_study_id>
    <nct_id>NCT02822885</nct_id>
  </id_info>
  <brief_title>Uterine Artery and Spiral Artery Doppler Parameters in Patients With Postmenopausal Bleeding</brief_title>
  <official_title>Uterine Artery and Spiral Artery Doppler Parameters in Patients With Postmenopausal Bleeding</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Benha University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Benha University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study was to investigate the diagnostic value of ultrasonography and blood flow
      measurements in uterine arteries and spiral arteries by transvaginal color Doppler
      ultrasonography in the detection of the endometrial pathology in women with postmenopausal
      bleeding.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This prospective Cross-sectional Observational study will be conducted at the Department of
      Obstetrics and Gynecology, Banha University, Egypt during the period starting from January
      2014. The study protocol will be approved by the Local Ethics Committee and written informed
      consent will be obtained from each patient before the study commenced.

      Seventy patients with postmenopausal bleeding will be included in the study after verbal
      consent. They will be recruited from patients attending gynecologic clinic in Banha
      University hospital.

      All patients will be subjected to the following:

      For all included women the following will be done:

        1. Full history taking.

        2. Complete general, abdominal, and local examination.

        3. Ultrasonographic assessment of the uterus

      All data were performed for all patients in the lithotomy position after they had emptied
      their bladder using a 7.5 megahertz transducer by a single operator.

        1. Using colour Doppler in the 2D mode, flow velocity waveforms were obtained from the
           ascending main branch of the uterine artery on the right and left side of the cervix in
           a longitudinal plane before they entered the uterus.

        2. The gate of the Doppler was positioned when the vessel with good colour signals was
           identified on the screen. Pulsatility index of the uterine arteries were calculated
           electronically when similar consecutive waveforms of good quality were obtained and the
           averaged uterine PI.

           Pulsatility index (PI):

           This index, also known as the mean pulsatility index, to distinguish it from the peak to
           peak pulsatility index, is expressed by: PI= (S-D) / Mean Where S is the peak systolic
           velocity, D is the end diastolic velocity and velocity is the time averaged maximum
           velocity over the cardiac cycle (1).

        3. Blood flow velocity waveforms were evaluated in the spiral arteries at the sub
           endometrial region that is within 1 mm of the originally defined myometrial-endometrial
           contour (2).

      Histopathological diagnosis of endometrium obtained by biopsy is the gold standard for
      diagnosis.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">April 2017</completion_date>
  <primary_completion_date type="Actual">November 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pulsatility Indices (PI) of Spiral Artery According to Histological Diagnosis</measure>
    <time_frame>two weeks</time_frame>
    <description>Pulsatility index is a measure of the variability of blood velocity in a vessel, and was calculated as the difference between the peak systolic and end diastolic velocities divided by the mean velocity during the cardiac cycle. Higher values are indicative of increased vascular resistance</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Resistive Indices (PI) of Spiral Artery According to Histological Diagnosis</measure>
    <time_frame>two weeks</time_frame>
    <description>The primary outcome measure is spiral artery resistive index (RI) .In ultrasonography,it can be calculated from the peak systolic velocity and end diastolic velocity of blood flow and is calculated with the following formula: (peak systolic velocity - end diastolic velocity)/peak systolic velocity.lower values are better than higher values.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Uterine Artery Resistive Index According to Histological Diagnosis</measure>
    <time_frame>two weeks</time_frame>
    <description>The primary outcome measures is uterine artery resistive index (RI) .In ultrasonography,it can be calculated from the peak systolic velocity and end diastolic velocity of blood flow and is calculated with the following formula: (peak systolic velocity - end diastolic velocity)/peak systolic velocity.lower values are better than higher values.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Uterine Artery Pulsatility Index According to Histological Diagnosis</measure>
    <time_frame>2 weeks</time_frame>
    <description>Pulsatility index is a measure of the variability of blood velocity in a vessel, and was calculated as the difference between the peak systolic and end diastolic velocities divided by the mean velocity during the cardiac cycle. Higher values are indicative of increased vascular resistance</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Endometrial Thickness According to Histological Diagnosis</measure>
    <time_frame>2 weeks</time_frame>
    <description>Endometrial Thickness was assessed by measuring the trilaminar halo of the Endometrial Thickness by trans vaginal sonography</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Postmenopausal Bleeding</condition>
  <arm_group>
    <arm_group_label>ultrasonography</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ultrasonographic assessment of the thickness of the endometrium of the uterus and transvaginal color Doppler ultrasonography for measurements of Pulsatility index and resistance indices of uterine arteries and spiral arteries</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Ultrasonography</intervention_name>
    <description>Ultrasonographic assessment of the thickness of the endometrium of the uterus and transvaginal color Doppler ultrasonography for measurements of Pulsatility index and resistance indices of uterine arteries and spiral arteries</description>
    <arm_group_label>ultrasonography</arm_group_label>
    <other_name>color Doppler ultrasonography</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Endometrial thickness ≥ 5 mm measured by two-dimensional transvaginal ultrasound.

          2. Pap smear is negative for malignancy.

        Exclusion Criteria:

          1. Postmenopausal woman on hormon replacement therapy.

          2. Trans-vaginal examination not possible (Vaginal stenosis or patient refusing
             trans-vaginal ultrasound).

          3. Adnexal pathology.

          4. General causes of bleeding e.g: Hemophilia , anticoagulation therapy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Moharam A ABDEL HAEY, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Benha University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>AHMED WALEED A Mrad, MD</last_name>
    <role>Study Director</role>
    <affiliation>Benha University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Benha university hospitalا</name>
      <address>
        <city>Benha</city>
        <state>Alqalubia</state>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <link>
    <url>http://www.bu.edu.eg</url>
    <description>Banha university</description>
  </link>
  <reference>
    <citation>Dickey RP. Doppler ultrasound investigation of uterine and ovarian blood flow in infertility and early pregnancy. Hum Reprod Update. 1997 Sep-Oct;3(5):467-503. Review.</citation>
    <PMID>9528912</PMID>
  </reference>
  <reference>
    <citation>Ng EH, Chan CC, Tang OS, Yeung WS, Ho PC. Endometrial and subendometrial blood flow measured during early luteal phase by three-dimensional power Doppler ultrasound in excessive ovarian responders. Hum Reprod. 2004 Apr;19(4):924-31. Epub 2004 Mar 11.</citation>
    <PMID>15016770</PMID>
  </reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 27, 2016</study_first_submitted>
  <study_first_submitted_qc>July 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 4, 2016</study_first_posted>
  <results_first_submitted>August 31, 2016</results_first_submitted>
  <results_first_submitted_qc>January 24, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">March 14, 2017</results_first_posted>
  <last_update_submitted>January 24, 2017</last_update_submitted>
  <last_update_submitted_qc>January 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Benha University</investigator_affiliation>
    <investigator_full_name>khalid mohammed salama</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Uterine Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Ultrasonography</title>
          <description>Ultrasonographic assessment of the thickness of the endometrium of the uterus and transvaginal color Doppler ultrasonography for measurements of Pulsatility index and resistance indices of uterine arteries and spiral arteries</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="70"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="70"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Ultrasonography</title>
          <description>Ultrasonographic assessment of the thickness of the endometrium of the uterus and transvaginal color Doppler ultrasonography for measurements of Pulsatility index and resistance indices of uterine arteries and spiral arteries
Ultrasonography: Ultrasonographic assessment of the thickness of the endometrium of the uterus and transvaginal color Doppler ultrasonography for measurements of Pulsatility index and resistance indices of uterine arteries and spiral arteries</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="70"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="59.85" spread="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="70"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Pulsatility Indices (PI) of Spiral Artery According to Histological Diagnosis</title>
        <description>Pulsatility index is a measure of the variability of blood velocity in a vessel, and was calculated as the difference between the peak systolic and end diastolic velocities divided by the mean velocity during the cardiac cycle. Higher values are indicative of increased vascular resistance</description>
        <time_frame>two weeks</time_frame>
        <population>All patients(N=70) were subdivided according to histological diagnosis to A-Benign lesion (N=60)
Endometrial polyp(N=17)
Hyperplasia(N=28)
Non-specific(N=15) B-Malignant lesion(N=10)</population>
        <group_list>
          <group group_id="O1">
            <title>Ultrasonography</title>
            <description>Ultrasonographic assessment of the thickness of the endometrium of the uterus and transvaginal color Doppler ultrasonography for measurements of Pulsatility index and resistance indices of uterine arteries and spiral arteries</description>
          </group>
        </group_list>
        <measure>
          <title>Pulsatility Indices (PI) of Spiral Artery According to Histological Diagnosis</title>
          <description>Pulsatility index is a measure of the variability of blood velocity in a vessel, and was calculated as the difference between the peak systolic and end diastolic velocities divided by the mean velocity during the cardiac cycle. Higher values are indicative of increased vascular resistance</description>
          <population>All patients(N=70) were subdivided according to histological diagnosis to A-Benign lesion (N=60)
Endometrial polyp(N=17)
Hyperplasia(N=28)
Non-specific(N=15) B-Malignant lesion(N=10)</population>
          <units>index</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>endometrial polyp(n=17)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.08" spread=".33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>endometrial Hyperplasia(n=28)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.22" spread="0.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>endometrialNon-specif lesions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.07" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>all endometrial benign lesions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.14" spread="0.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>endometrial cancer(n=10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.57" spread="0.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>All included p-values are calculated from collected data and not threshold values for statical significance</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Resistive Indices (PI) of Spiral Artery According to Histological Diagnosis</title>
        <description>The primary outcome measure is spiral artery resistive index (RI) .In ultrasonography,it can be calculated from the peak systolic velocity and end diastolic velocity of blood flow and is calculated with the following formula: (peak systolic velocity – end diastolic velocity)/peak systolic velocity.lower values are better than higher values.</description>
        <time_frame>two weeks</time_frame>
        <population>All patients(N=70) were subdivided according to histological diagnosis to A-Benign lesion (N=60)
Endometrial polyp(N=17)
Hyperplasia(N=28)
Non-specific(N=15) B-Malignant lesion(N=10)</population>
        <group_list>
          <group group_id="O1">
            <title>Ultrasonography</title>
            <description>Ultrasonographic assessment of the thickness of the endometrium of the uterus and transvaginal color Doppler ultrasonography for measurements of Pulsatility index and resistance indices of uterine arteries and spiral arteries</description>
          </group>
        </group_list>
        <measure>
          <title>Resistive Indices (PI) of Spiral Artery According to Histological Diagnosis</title>
          <description>The primary outcome measure is spiral artery resistive index (RI) .In ultrasonography,it can be calculated from the peak systolic velocity and end diastolic velocity of blood flow and is calculated with the following formula: (peak systolic velocity – end diastolic velocity)/peak systolic velocity.lower values are better than higher values.</description>
          <population>All patients(N=70) were subdivided according to histological diagnosis to A-Benign lesion (N=60)
Endometrial polyp(N=17)
Hyperplasia(N=28)
Non-specific(N=15) B-Malignant lesion(N=10)</population>
          <units>index</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>endometrial polyp(n=17)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.62" spread="0.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>endometrial hyperplasia(n=28)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.68" spread="0.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-specif endometrial lesions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.58" spread="0.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>all benig endometrial lesions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.64" spread="0.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>endometrial cancer(n=10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.46" spread="0.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>All included p-values are calculated from collected data and not threshold values for statical significance</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Uterine Artery Resistive Index According to Histological Diagnosis</title>
        <description>The primary outcome measures is uterine artery resistive index (RI) .In ultrasonography,it can be calculated from the peak systolic velocity and end diastolic velocity of blood flow and is calculated with the following formula: (peak systolic velocity – end diastolic velocity)/peak systolic velocity.lower values are better than higher values.</description>
        <time_frame>two weeks</time_frame>
        <population>All patients(N=70) were subdivided according to histological diagnosis to A-Benign lesion (N=60)
Endometrial polyp(N=17)
Hyperplasia(N=28)
Non-specific(N=15) B-Malignant lesion(N=10)</population>
        <group_list>
          <group group_id="O1">
            <title>Ultrasonography</title>
            <description>Ultrasonographic assessment of the thickness of the endometrium of the uterus and transvaginal color Doppler ultrasonography for measurements of Pulsatility index and resistance indices of uterine arteries and spiral arteries</description>
          </group>
        </group_list>
        <measure>
          <title>Uterine Artery Resistive Index According to Histological Diagnosis</title>
          <description>The primary outcome measures is uterine artery resistive index (RI) .In ultrasonography,it can be calculated from the peak systolic velocity and end diastolic velocity of blood flow and is calculated with the following formula: (peak systolic velocity – end diastolic velocity)/peak systolic velocity.lower values are better than higher values.</description>
          <population>All patients(N=70) were subdivided according to histological diagnosis to A-Benign lesion (N=60)
Endometrial polyp(N=17)
Hyperplasia(N=28)
Non-specific(N=15) B-Malignant lesion(N=10)</population>
          <units>index</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>endometrial polyp.(n=17)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.68" spread="0.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>endometrial hyperplasia.(n=28)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.79" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>non specifi endometrial lesions.</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.73" spread="0.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>all benign endometrial lesions.</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.74" spread="0.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>endometrial cancer(n=10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.51" spread="0.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>All included p-values are calculated from collected data and not threshold values for statical significance</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Uterine Artery Pulsatility Index According to Histological Diagnosis</title>
        <description>Pulsatility index is a measure of the variability of blood velocity in a vessel, and was calculated as the difference between the peak systolic and end diastolic velocities divided by the mean velocity during the cardiac cycle. Higher values are indicative of increased vascular resistance</description>
        <time_frame>2 weeks</time_frame>
        <population>All patients(N=70) were subdivided according to histological diagnosis to A-Benign lesion (N=60)
Endometrial polyp(N=17)
Hyperplasia(N=28)
Non-specific(N=15) B-Malignant lesion(N=10)</population>
        <group_list>
          <group group_id="O1">
            <title>Ultrasonography</title>
            <description>Ultrasonographic assessment of the thickness of the endometrium of the uterus and transvaginal color Doppler ultrasonography for measurements of Pulsatility index and resistance indices of uterine arteries and spiral arteries</description>
          </group>
        </group_list>
        <measure>
          <title>Uterine Artery Pulsatility Index According to Histological Diagnosis</title>
          <description>Pulsatility index is a measure of the variability of blood velocity in a vessel, and was calculated as the difference between the peak systolic and end diastolic velocities divided by the mean velocity during the cardiac cycle. Higher values are indicative of increased vascular resistance</description>
          <population>All patients(N=70) were subdivided according to histological diagnosis to A-Benign lesion (N=60)
Endometrial polyp(N=17)
Hyperplasia(N=28)
Non-specific(N=15) B-Malignant lesion(N=10)</population>
          <units>index</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>endometrial polyp</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.94" spread="0.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>endometrial hyperplasia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.21" spread="0.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>un specific endometrial lesions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.88" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>all benign endometrial lesions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.05" spread="0.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>endometrial cancer lesions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.65" spread="0.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>All included p-values are calculated from collected data and not threshold values for statical significance</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Endometrial Thickness According to Histological Diagnosis</title>
        <description>Endometrial Thickness was assessed by measuring the trilaminar halo of the Endometrial Thickness by trans vaginal sonography</description>
        <time_frame>2 weeks</time_frame>
        <population>All patients(N=70) were subdivided according to histological diagnosis to A-Benign lesion (N=60)
Endometrial polyp(N=17)
Hyperplasia(N=28)
Non-specific(N=15) B-Malignant lesion(N=10)</population>
        <group_list>
          <group group_id="O1">
            <title>Ultrasonography</title>
            <description>Ultrasonographic assessment of the thickness of the endometrium of the uterus and transvaginal color Doppler ultrasonography for measurements of Pulsatility index and resistance indices of uterine arteries and spiral arteries</description>
          </group>
        </group_list>
        <measure>
          <title>Endometrial Thickness According to Histological Diagnosis</title>
          <description>Endometrial Thickness was assessed by measuring the trilaminar halo of the Endometrial Thickness by trans vaginal sonography</description>
          <population>All patients(N=70) were subdivided according to histological diagnosis to A-Benign lesion (N=60)
Endometrial polyp(N=17)
Hyperplasia(N=28)
Non-specific(N=15) B-Malignant lesion(N=10)</population>
          <units>millimeter</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>endometrial polyp</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18" spread="3.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>endometrial hyperplasia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.98" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>un specific lesions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.56" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>all benign lesions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.215" spread="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>endometrial cancer</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.8" spread="3.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>All included p-values are calculated from collected data and not threshold values for statical significance</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Ultrasonography</title>
          <description>Ultrasonographic assessment of the thickness of the endometrium of the uterus and transvaginal color Doppler ultrasonography for measurements of Pulsatility index and resistance indices of uterine arteries and spiral arteries</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="70"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="70"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>dr khalid M Salama</name_or_title>
      <organization>Benha university</organization>
      <phone>01225861026</phone>
      <email>dr.khalid_sleem@yahoo.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

